PIK3CA and colonic neoplasm: While the side effects of these drugs have temporary biased their extended use in chronic regimens, the recent finding of a correlation between PIK3CA mutation in colon tumors and an increased survival of patients under long-term aspirin therapy at diagnosis [52], indicates the need for specific markers identifying responders to NSAIDS regimen.